The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Areas Suspicious for Prostate Cancer: MR–guided Biopsy in Patients with at Least One Transrectal US-guided Biopsy with a Negative Finding—Multiparametric MR Imaging for Detection and Biopsy Planning
Abstract
PURPOSE: To prospectively investigate the incremental value of multiparametric magnetic resonance (MR) imaging compared with standard T2-weighted imaging for biopsy planning. MATERIALS AND METHODS: The study was approved by the institutional review board; informed consent was obtained. Consecutive patients underwent T2-weighted imaging supplemented with multiparametric 1.5-T MR imaging, consisting of hydrogen 1 ((1)H) MR spectroscopy, diffusion-weighted (DW) imaging, and contrast material-enhanced MR imaging. Quantitative parameters were calculated: (choline plus creatine)-to-citrate ratio, apparent diffusion coefficient, and volume transfer constant and exchange rate constant. The prostate was divided into 20 standardized areas. Each area was classified as benign, inconclusive, or suspicious at T2-weighted imaging, followed by quantitative evaluation of all inconclusive and suspicious areas with multiparametric MR imaging. MR-guided biopsy was performed in lesions classified as suspicious for cancer with at least one of the techniques after transfer to three-dimensional T2-weighted images. Diagnostic parameters were calculated on a per-lesion and per-patient basis for all combinations of T2-weighted imaging with multiparametric MR imaging. RESULTS: Fifty-four patients had a median of two prior transrectal ultrasonographic biopsies with negative findings. Each patient had a median of three suspicious lesions. Prostate cancer was demonstrated in 21 of 54 patients. Biopsy was performed in 178 lesions; 53 were positive for prostate cancer. Detection rates and test negative results, respectively, were as follows: T2-weighted imaging, 70% and 50%; T2-weighted imaging and (1)H MR spectroscopy, 81% and 32%; T2-weighted imaging and contrast-enhanced MR imaging, 83% and 29%; T2-weighted imaging and DW imaging, 85% and 30%; T2-weighted imaging, (1)H MR spectroscopy, and contrast-enhanced MR imaging, 91% and 13%; T2-weighted imaging, (1)H MR spectroscopy, and DW imaging, 94% and 15%; T2-weighted imaging, DW imaging, and contrast-enhanced MR imaging, 94% and 13%; T2-weighted imaging, (1)H MR spectroscopy, DW imaging, and contrast-enhanced MR imaging, 100% and 0%. CONCLUSION: Only the combination of T2-weighted imaging with all three multiparametric techniques depicts all identifiable prostate cancers; a double combination with DW imaging and (1)H MR spectroscopy or contrast-enhanced MR imaging misses 6%, while reasonably reducing the number of areas needing biopsy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20006 · Cited by 9,709
Cited by
ESUR prostate MR guidelines 2012
Barentsz, J. O., Richenberg, J., Clements, R., Choyke, P., Verma, S., Villeirs, G., Rouviere, O., Logager, V., & Fütterer, J. J. (2012) · European Radiology · doi:10.1007/s00330-011-2377-y · Cited by 2,438
Prostate Cancer: Multiparametric MR Imaging for Detection, Localization, and Staging
Hoeks, C. M. A., Barentsz, J. O., Hambrock, T., Yakar, D., Somford, D. M., Heijmink, S. W. T. P. J., Scheenen, T. W. J., Vos, P. C., Huisman, H., van Oort, I. M., et al. (2011) · Radiology · doi:10.1148/radiol.11091822 · Cited by 677
Image-Guided Prostate Biopsy Using Magnetic Resonance Imaging–Derived Targets: A Systematic Review
Moore, C. M., Robertson, N. L., Arsanious, N., Middleton, T., Villers, A., Klotz, L., Taneja, S. S., & Emberton, M. (2013) · European Urology · doi:10.1016/j.eururo.2012.06.004 · Cited by 535
Wegelin, O., van Melick, H. H. E., Hooft, L., Bosch, J. L. H. R., Reitsma, H. B., Barentsz, J. O., & Somford, D. M. (2017) · European Urology · doi:10.1016/j.eururo.2016.07.041 · Cited by 425
Sonn, G. A., Chang, E., Natarajan, S., Margolis, D. J., Macairan, M., Lieu, P., Huang, J., Dorey, F. J., Reiter, R. E., & Marks, L. S. (2014) · European Urology · doi:10.1016/j.eururo.2013.03.025 · Cited by 371
Metadata
- Authors
- Franiel, T., Stephan, C., Erbersdobler, A., Dietz, E., Maxeiner, A., Hell, N., Huppertz, A., Miller, K., Strecker, R., & Hamm, B.
- Venue
- Radiology
- Published
- 2011-04
- Volume
- 259
- Issue
- 1
- Pages
- 162-172
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2169258415
- Cited by
- 173
- References
- 1
- FWCI
- 23.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Areas Suspicious for Prostate Cancer: MR–guided Biopsy in Patients with at Least One Transrectal US-guided Biopsy with a Negative Finding—Multiparametric MR Imaging for Detection and Biopsy Planning. https://app.cochat.ai/papers/10.1148/radiol.10101251
- The paper
- Franiel, T., Stephan, C., Erbersdobler, A., Dietz, E., Maxeiner, A., Hell, N., Huppertz, A., Miller, K., Strecker, R., & Hamm, B. (2011). Areas Suspicious for Prostate Cancer: MR–guided Biopsy in Patients with at Least One Transrectal US-guided Biopsy with a Negative Finding—Multiparametric MR Imaging for Detection and Biopsy Planning. Radiology. https://doi.org/10.1148/radiol.10101251
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.